Results

eNauka >  Results >  Long-Term Safety, Tolerability, and Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Interim Results of the Adapt plus Study
Title: Long-Term Safety, Tolerability, and Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Interim Results of the Adapt plus Study
Authors: Howard, James F Jr.; Bril, Vera; Tuan, Vu; Karam, Chafic; Perić, Stojan Z.  ; De Bleecker, Jan L.; Murai, Hiroyuki; Meisel, Andreas; Beydoun, Said; Pasnoor, Mamatha;
Issue Date: 2022
Publication: Muscle & Nerve (Myasthenia-Gravis-Foundation-of-America's 14th International Conference on Myasthenia Gravis and Related Disorders, Miami, FL, May 10-12, 2022)
ISSN: 0148-639X Muscle and Nerve Search Idenfier
Publisher: Hoboken, NJ : John Wiley & Sons
Type: Conference Paper
Collation: vol. 65 br. Suppl 1 str. S9-S10
WoS-ID: 000813311100019
URI: https://enauka.gov.rs/handle/123456789/819319
URL: https://doi.org/10.1002/mus.27683
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Find the DOI


Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.